Insulin Aspart

From WikiMD.org
Jump to navigation Jump to search

Insulin Aspart

Insulin Aspart (pronounced as IN-su-lin AS-part) is a fast-acting insulin analog marketed by Novo Nordisk as a product under the trade name NovoLog/NovoRapid.

Etymology

The term "Insulin Aspart" is derived from the scientific name for the compound, which is B28 aspart insulin. The "aspart" in the name refers to the substitution of the amino acid proline with aspartic acid at position B28 in the insulin molecule.

Pharmacology

Insulin Aspart is a recombinant, biosynthetic, fast-acting insulin analog. It has a faster onset of action compared to regular human insulin. It is produced using recombinant DNA technology, altering the amino acid sequence of standard human insulin to achieve its rapid-acting properties.

Usage

Insulin Aspart is used to improve glycemic control in adults and children with diabetes mellitus.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski